Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 4 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Active Not Recruiting1
Recruiting1
Unknown1
Completed1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 1 completed trials

Clinical Trials (4)

Showing 4 of 4 trials
NCT06304415Active Not Recruiting

Elevated Lipoprotein(a) in Hospital Staff

NCT06439654Not ApplicableRecruiting

Atlantic Lipid Lowering Treatment Optimization Program

NCT02791802UnknownPrimary

Effect of Lipoprotein(a) Elimination by Lipoprotein Apheresis on Cardiovascular Outcomes

NCT01753232Completed

Safety and Efficacy of the DALI LDL-adsorber and MONET Lipoprotein Filter

Showing all 4 trials

Research Network

Activity Timeline